Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Edesa Biotech Inc (EDSA) COM NPV

Sell:$4.71 Buy:$4.95 Change: $0.34 (6.69%)
NASDAQ:0.24%
Market closed |  Prices as at close on 21 November 2019 | Switch to live prices |
Sell:$4.71
Buy:$4.95
Change: $0.34 (6.69%)
Market closed |  Prices as at close on 21 November 2019 | Switch to live prices |
Sell:$4.71
Buy:$4.95
Change: $0.34 (6.69%)
Market closed |  Prices as at close on 21 November 2019 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Edesa Biotech Inc., Stellar Biotechnologies, Inc., is a clinical-stage biopharmaceutical company. The Company is focused on the development of therapeutics for dermatological and gastrointestinal indications. The Company’s lead product candidate, EB01, is a novel non-steroidal anti-inflammatory molecule (sPLA2 inhibitor) for the treatment of chronic allergic contact dermatitis. The Company has its operations in the United States and in Canada.

Contact details

Address:
100 Spy Crt
MARKHAM
L3R 5H6
Canada
Telephone:
+1 (905) 4751234
Website:
https://stellarbiotechnologies.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
EDSA
ISIN:
CA27966L1085
Market cap:
$38.12 million
Shares in issue:
7.50 million
Sector:
Biotechnology
Exchange:
NASDAQ
Country:
Canada
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel

  • Sean MacDonald
    Independent Chairman of Board
  • Michael Brooks
    President
  • Pardeep Nijhawan
    Chief Executive Officer, Director
  • Kathi Niffenegger
    Chief Financial Officer, Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.